“The rise in antibodies is not very impressive”

Few branches, but a lot of staff

Pharmaceutical industry is realigning itself

You should watch out for these companies

Pharmaceutical industry is realigning itself

Large chains expand, small studios suffer

More evidence of milder symptoms with Omikron